RopesTalk

In this edition of Ropes & Gray’s podcast series On the Ropes: Enforcement Risk Roundtable, litigation and enforcement associate Patrick Doherty is joined by Stéphane de Navacelle, managing partner of Navacelle in Paris, to discuss the current anti-corruption landscape in France and related legal considerations for businesses and individuals operating in the country.

On this episode of Scope of Practice, Ropes & Gray asset management associate, Yoni Levy, speaks with Kyle Higley, who was recently promoted to partner in the firm’s employment, executive compensation & benefits group, about his practice and to discuss the roles and responsibilities of an associate in the firm.

In this episode of Trainee Insights, Ropes & Gray London asset management counsel, Chris Townsend, speaks about life as a private funds lawyer and shares his experiences on how to make the best possible start as a junior lawyer and, most importantly, maintain that standard throughout a career. Chris also gives tips on how to achieve high performance at the junior level and offers valuable insights into how you can “work smart.”

On this episode of Scope of Practice, Ropes & Gray asset management associate, Yoni Levy, speaks with asset management associate, Chelsea Childs, about her practice, which is split across registered funds and private funds work, as well as the firm’s San Francisco office.

In this Ropes & Gray podcast, asset management partners Joel Wattenbarger and Jason Brown discuss the regulatory consequences of recent enforcement actions involving management fee calculation and offset issues, and their respective electronic communication recordkeeping requirements. The Private Fund Regulatory Update is a series of podcasts discussing key issues of interest and updates in the regulatory and compliance space, focusing in particular on private fund managers.

In this episode of Women @ RopesTalk, hosted by health care partner Christine Moundas, life sciences partner and Women’s Forum co-chair Katherine Wang interviews Ingrid Zhang, president of Novartis Pharmaceuticals China. Ingrid talks about her early interest in health care and why she decided to go to business school. As she reflects on her career path, from consulting to working in the pharmaceutical industry, Ingrid shares her advice for early career professionals, especially why developing a thick skin is so important for growth. She also describes the exciting regulatory changes in China’s health care market, as well as unique aspects of Novartis’s culture.

In the latest installment of our Ropes & Gray podcast series addressing emerging issues for fiduciaries of 401(k) and 403(b) plans to consider as part of their litigation risk management strategy, ERISA and benefits partner Josh Lichtenstein, counsel Sharon Remmer, and associate Jon Reinstein continue the discussion from our prior episode about the Department of Labor’s proposed regulation pertaining to ERISA investment duties and ESG considerations, by focusing on (i) how the rule might change the market for retirement plan investing and (ii) what impact it could have on plan investment committees and asset managers who manage plan assets.

Welcome to Scope of Practice, a new Ropes & Gray podcast series for law students and recent graduates that provides an inside look into different practice groups and the lives of attorneys in those groups at the firm. In this inaugural episode, asset management associate and host, Yoni Levy, speaks with asset management associate, Young Yoon, about life as an associate in the private funds practice at the firm.

This installation of Ropes & Gray’s podcast series Non-binding Guidance focuses on recent developments in FDA inspection policy, including implications of the pandemic-related slowdown on product quality and approval delays as well as progress FDA has been making in clearing the inspection backlog. In March 2020, many routine inspections, such as foreign pre-approval and for-cause inspection assignments not deemed “mission-critical,” were temporarily postponed, but FDA has recently restarted some inspections. In this episode, Ropes & Gray life sciences regulatory & compliance practice group leader, Greg Levine, and Ropes & Gray counsel and former FDA Office of Chief Counsel attorney, Beth Weinman, discuss the significance of these developments and what FDA-regulated entities can expect when thinking about and preparing for FDA inspections in 2022.